EXPE vs SILO · P/E 20, rev $7.74B vs rev $18.0K
Expedia Group Inc. (EXPE) versus Silo Pharma Inc (SILO) — a side-by-side from cached financials, not a winner call.
Expedia Group Inc. (EXPE) is a travel services company listed on US.
Silo Pharma Inc (SILO) is a biotechnology company listed on US.
Latest reported EXPE revenue for 2026-06-30 was $7.74B. Net income was $872.0M. EXPE currently screens at market cap $21.71B and trailing P/E 20.4.
Latest reported SILO revenue for 2026-06-30 was $18.0K. Net income was -$2.5M. Revenue was up 0.0% from 2026-03-31 to 2026-06-30. SILO currently screens at market cap $4.4M.
EXPE currently screens at market cap $21.71B and trailing P/E 20.4. SILO currently screens at market cap $4.4M.
Not investment advice. Open the EXPE and SILO stock pages for the full models.
Not investment advice.